1.25
+2.46%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Petmed Express
From its filings with the US Securities and Exchange Commission
Petmed Express is based in Delray Beach, Florida and is incorporated in Florida. Its shares trade on Nasdaq under the ticker PETS. The SEC classifies its business as retail-drug stores and proprietary stores. In the fiscal year to 31 March 2026, it reported revenue of $179.0m and a net loss of $57.3m. At that date it held total assets of $81.2m and shareholders' equity of $28.9m.
We are deeply committed to the mission and purpose that has driven our business from the start. Since our founding, we have fulfilled orders for almost twenty-million pet parents in all 50 states and have been instrumental in providing products that help pets live longer, healthier lives. The support of our customers nationwide has been the cornerstone of our success. Honoring our combined legacy, we bring our core values to every role we undertake as we empower pet families, ensuring they have access to products and services that can provide the best possible care for their dogs, cats, and horses.
Over the years, our organization has made investments in our pharmacies to ensure regulatory compliance, accreditations, and operational excellence which include implementing a rigorous verification process from order to shipment to ensure top quality control. Employing licensed pharmacists and a 50-state licensed Pharmacist-in-Charge for each of our two pharmacy locations, allows us to provide focused and specialized care backed by expertise. We continuously monitor and update our regulatory licenses in every state, as well as the U.S. Virgin Islands. Our pharmacies are accredited by the National Association of Boards of Pharmacy ("NABP") and LegitScript and are focused on compliance with all federal and state regulatory requirements.
Quoted from its 10-K, filed 2 Jun 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Consumer Discretionary
- Industry
- Internet & Direct Marketing Retail
- Listed since
- 6 Apr 2000
- Employees
- 189
- Website
- 1800petmeds.com ↗
- Head office
- 420 SOUTH CONGRESS AVENUE, DELRAY BEACH, FL, 33445
- Incorporated in
- FL
- Classification
- Retail-Drug Stores and Proprietary Stores
- Filer status
- Non-accelerated filer<br>Smaller reporting company
Leadership
Pay as last reported
- Ms. Leslie CampbellChairman of the Board, President, Interim Chief Executive Officer, since 2018$143,069
- Mr. Doug KrulikInterim Chief Financial Officer, Chief Accounting Officer
- Ms. Caroline ConeglianoChief Operating Officer
- Mr. Umesh SripadChief Digital and Technology Officer
- Ms. Carla DoddsChief Marketing Officer
- Mr. Peter BatushanskyDirector
- Mr. Justin MennenIndependent Director
- Ms. Leah SolivanIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 41
- Environment
- 6
- Social
- 35
- Governance
- 81
- Women in the workforce
- 69%
- Carbon reduction policy
- No
- Human rights policy
- No
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Petmed Express Inc. has several strengths that contribute to its success in the market. Firstly, the company has a strong brand reputation and recognition in the pet medication industry. This reputation has been built through years of providing quality and reliable pet medications and services to its customers. Additionally, Petmed Express Inc. has a wide range of products, offering a comprehensive selection of medications and supplies for pets. This diverse product portfolio allows the company to cater to the varied needs of pet owners.
Weaknesses
- Petmed Express Inc. also faces certain weaknesses that may hinder its growth and profitability. One key weakness is the company's limited geographical presence. While Petmed Express Inc. operates nationally, it may not have the same level of reach and accessibility as some of its competitors. Additionally, the company heavily relies on third-party manufacturers and suppliers for its products. This dependence on external sources may lead to potential disruptions in the supply chain or quality control issues.
Opportunities
- There are several opportunities for Petmed Express Inc. to explore and expand its business. One significant opportunity is the growing pet ownership and pet healthcare market. As more individuals are adopting pets and becoming pet owners, there is an increased demand for pet medications and related services. By capitalizing on this trend, Petmed Express Inc. can tap into a larger customer base and potentially increase its market share. Additionally, the company can also consider expanding its product offerings to include specialized pet care services, such as grooming or training, to cater to the evolving needs of pet owners.
Threats
- Petmed Express Inc. faces various threats that may pose challenges to its operations and position in the market. One major threat is the presence of intense competition in the pet medication industry. There are numerous competitors, including traditional brick-and-mortar stores and online retailers, offering similar products and services. This competitive landscape may lead to price wars and margin pressures. Moreover, the industry is subject to stringent regulations and compliance requirements, which may increase operational costs and create barriers to entry for new players.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.